These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2509)

  • 1. The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.
    Feinstein PA; Kaplan SR; Thayer WR
    Gastroenterology; 1976 Feb; 70(2):181-5. PubMed ID: 2509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
    Ward M; Eastwood MA
    Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune system activity in inflammatory bowel disease.
    Teisberg P; Gjone E
    Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune system in inflammatory bowel disease: I. Complement levels.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement alterations in inflammatory bowel disease.
    Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
    Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum complement levels in patients with gastrointestinal disease.
    Ross IN; Thompson RA; Montgomery RD; Asquith P
    J Clin Pathol; 1979 Aug; 32(8):798-801. PubMed ID: 512040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 metabolism in ulcerative colitis and Crohn's disease.
    Hodgson HJ; Potter BJ; Jewell DP
    Clin Exp Immunol; 1977 Jun; 28(3):490-5. PubMed ID: 891024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
    Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
    Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease.
    Elmgreen J; Sørensen H; Berkowicz A
    Acta Med Scand; 1984; 215(4):375-8. PubMed ID: 6731047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c.
    Elmgreen J; Berkowicz A; Sørensen H
    Acta Med Scand; 1983; 214(5):403-7. PubMed ID: 6660048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease.
    Ward M; Eastwood MA
    Gut; 1974 Oct; 15(10):835. PubMed ID: 4215646
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
    Potter BJ; Brown DJ; Watson A; Jewell DP
    Gut; 1980 Dec; 21(12):1030-4. PubMed ID: 6450718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
    N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement.
    Elmgreen J; Both H; Binder V
    Gut; 1985 Feb; 26(2):151-7. PubMed ID: 3967833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological differential diagnosis of inflammatory colonic diseases.
    Schneider HM; Loos M; Störkel S; Gross M
    Histopathology; 1984 Jul; 8(4):583-8. PubMed ID: 6332771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alternative pathway of complement activation in the neonate.
    Feinstein PA; Kaplan SR
    Pediatr Res; 1975 Oct; 9(10):803-6. PubMed ID: 1103071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Complement in inflammatory bowel disease.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1975 Oct; 16(10):833-4. PubMed ID: 1205305
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.